ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair.

Farah Ballout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.